Literature DB >> 22782207

Genetic polymorphisms for estimating risk of atrial fibrillation in the general population: a prospective study.

J Gustav Smith1, Christopher Newton-Cheh, Peter Almgren, Olle Melander, Pyotr G Platonov.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22782207      PMCID: PMC3763742          DOI: 10.1001/archinternmed.2012.786

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  7 in total

1.  Lack of replication in polymorphisms reported to be associated with atrial fibrillation.

Authors:  Moritz F Sinner; Steven A Lubitz; Arne Pfeufer; Seiko Makino; Britt-Maria Beckmann; Kathryn L Lunetta; Gerhard Steinbeck; Siegfried Perz; Rosanna Rahman; Akshata Sonni; Steven M Greenberg; Karen L Furie; H-Erich Wichmann; Thomas Meitinger; Annette Peters; Emelia J Benjamin; Jonathan Rosand; Patrick T Ellinor; Stefan Kääb
Journal:  Heart Rhythm       Date:  2010-11-04       Impact factor: 6.343

2.  A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study).

Authors:  Alanna M Chamberlain; Sunil K Agarwal; Aaron R Folsom; Elsayed Z Soliman; Lloyd E Chambless; Richard Crow; Marietta Ambrose; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2011-01       Impact factor: 2.778

3.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry.

Authors:  Emelia J Benjamin; Kenneth M Rice; Dan E Arking; Arne Pfeufer; Charlotte van Noord; Albert V Smith; Renate B Schnabel; Joshua C Bis; Eric Boerwinkle; Moritz F Sinner; Abbas Dehghan; Steven A Lubitz; Ralph B D'Agostino; Thomas Lumley; Georg B Ehret; Jan Heeringa; Thor Aspelund; Christopher Newton-Cheh; Martin G Larson; Kristin D Marciante; Elsayed Z Soliman; Fernando Rivadeneira; Thomas J Wang; Gudny Eiríksdottir; Daniel Levy; Bruce M Psaty; Man Li; Alanna M Chamberlain; Albert Hofman; Ramachandran S Vasan; Tamara B Harris; Jerome I Rotter; W H Linda Kao; Sunil K Agarwal; Bruno H Ch Stricker; Ke Wang; Lenore J Launer; Nicholas L Smith; Aravinda Chakravarti; André G Uitterlinden; Philip A Wolf; Nona Sotoodehnia; Anna Köttgen; Cornelia M van Duijn; Thomas Meitinger; Martina Mueller; Siegfried Perz; Gerhard Steinbeck; H-Erich Wichmann; Kathryn L Lunetta; Susan R Heckbert; Vilmundur Gudnason; Alvaro Alonso; Stefan Kääb; Patrick T Ellinor; Jacqueline C M Witteman
Journal:  Nat Genet       Date:  2009-07-13       Impact factor: 38.330

4.  Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity.

Authors:  J Gustav Smith; Pyotr G Platonov; Bo Hedblad; Gunnar Engström; Olle Melander
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

5.  The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG).

Authors:  Moritz F Sinner; Arne Pfeufer; Mahmut Akyol; Britt-Maria Beckmann; Martin Hinterseer; Annette Wacker; Siegfried Perz; Wiebke Sauter; Thomas Illig; Michael Näbauer; Claus Schmitt; H-Erich Wichmann; Albert Schömig; Gerhard Steinbeck; Thomas Meitinger; Stefan Kääb
Journal:  Eur Heart J       Date:  2008-01-25       Impact factor: 29.983

6.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Authors:  Renate B Schnabel; Lisa M Sullivan; Daniel Levy; Michael J Pencina; Joseph M Massaro; Ralph B D'Agostino; Christopher Newton-Cheh; Jennifer F Yamamoto; Jared W Magnani; Thomas M Tadros; William B Kannel; Thomas J Wang; Patrick T Ellinor; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

7.  Variants conferring risk of atrial fibrillation on chromosome 4q25.

Authors:  Daniel F Gudbjartsson; David O Arnar; Anna Helgadottir; Solveig Gretarsdottir; Hilma Holm; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Adam Baker; Gudmar Thorleifsson; Kristleifur Kristjansson; Arnar Palsson; Thorarinn Blondal; Patrick Sulem; Valgerdur M Backman; Gudmundur A Hardarson; Ebba Palsdottir; Agnar Helgason; Runa Sigurjonsdottir; Jon T Sverrisson; Konstantinos Kostulas; Maggie C Y Ng; Larry Baum; Wing Yee So; Ka Sing Wong; Juliana C N Chan; Karen L Furie; Steven M Greenberg; Michelle Sale; Peter Kelly; Calum A MacRae; Eric E Smith; Jonathan Rosand; Jan Hillert; Ronald C W Ma; Patrick T Ellinor; Gudmundur Thorgeirsson; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nature       Date:  2007-07-01       Impact factor: 49.962

  7 in total
  9 in total

1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

2.  Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese.

Authors:  Steven A Lubitz; Kathryn L Lunetta; Honghuang Lin; Dan E Arking; Stella Trompet; Guo Li; Bouwe P Krijthe; Daniel I Chasman; John Barnard; Marcus E Kleber; Marcus Dörr; Kouichi Ozaki; Albert V Smith; Martina Müller-Nurasyid; Stefan Walter; Joanne M Murabito; Moritz F Sinner; Vilmundur Gudnason; Stephan B Felix; Winfried März; Mina Chung; Christine M Albert; Bruno H Stricker; Toshihiro Tanaka; Susan R Heckbert; J Wouter Jukema; Alvaro Alonso; Emelia J Benjamin; Patrick T Ellinor; Sunil K Agarwal; Joshua C Bis; Jennifer A Brody; Lin Y Chen; Brendan M Everett; Ian Ford; Oscar H Franco; Tamara B Harris; Albert Hofman; Stefan Kääb; Saagar Mahida; Sekar Kathiresan; Michiaki Kubo; Lenore J Launer; Peter W MacFarlane; Jared W Magnani; Barbara McKnight; David D McManus; Annette Peters; Bruce M Psaty; Lynda M Rose; Jerome I Rotter; Guenther Silbernagel; Jonathan D Smith; Nona Sotoodehnia; David J Stott; Kent D Taylor; Andreas Tomaschitz; Tatsuhiko Tsunoda; Andre G Uitterlinden; David R Van Wagoner; Uwe Völker; Henry Völzke
Journal:  J Am Coll Cardiol       Date:  2014-01-30       Impact factor: 24.094

3.  Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice.

Authors:  Saagar Mahida
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

4.  Genetic polymorphisms confer risk of atrial fibrillation in patients with heart failure: a population-based study.

Authors:  J Gustav Smith; Olle Melander; Marketa Sjögren; Bo Hedblad; Gunnar Engström; Christopher Newton-Cheh; Pyotr G Platonov
Journal:  Eur J Heart Fail       Date:  2012-11-06       Impact factor: 15.534

Review 5.  New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillation.

Authors:  Jelena Kornej; Vanessa A Hanger; Ludovic Trinquart; Darae Ko; Sarah R Preis; Emelia J Benjamin; Honghuang Lin
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

Review 6.  Personalized medicine and atrial fibrillation: will it ever happen?

Authors:  Steven A Lubitz; Patrick T Ellinor
Journal:  BMC Med       Date:  2012-12-04       Impact factor: 8.775

7.  Detection of paroxysmal atrial fibrillation in stroke/tia patients.

Authors:  Muhib Khan; Daniel J Miller
Journal:  Stroke Res Treat       Date:  2013-03-26

8.  Novel genetic markers improve measures of atrial fibrillation risk prediction.

Authors:  Brendan M Everett; Nancy R Cook; David Conen; Daniel I Chasman; Paul M Ridker; Christine M Albert
Journal:  Eur Heart J       Date:  2013-02-26       Impact factor: 29.983

9.  Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.

Authors:  Rungroj Krittayaphong; Ram Rangsin; Bandit Thinkhamrop; Cameron Hurst; Suthee Rattanamongkolgul; Nintita Sripaiboonkij; Ahthit Yindeengam
Journal:  BMC Cardiovasc Disord       Date:  2016-03-22       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.